Johnston Lloyd P. has filed 6 insider transactions across 1 company since January 2023.
Most recent transaction: a sale of 6381 shares of Cartesian Therapeutics, Inc. ($RNAC) on January 04, 2023.
Activity breakdown: 0 open-market purchases and 4 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 4, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Johnston Lloyd P. | Chief Operations Officer | S | Common Stock | 6381 | $1.13 | 268,918.0000 | 5,101,459 | 2.32% | 0.13% |
| Jan. 4, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Johnston Lloyd P. | Chief Operations Officer | S | Common Stock | 11 | $1.14 | 268,907.0000 | 5,101,459 | 0.00% | 0.00% |
| Jan. 5, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Johnston Lloyd P. | Chief Operations Officer | S | Common Stock | 3372 | $1.13 | 265,535.0000 | 5,101,459 | 1.25% | 0.07% |
| Jan. 5, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Johnston Lloyd P. | Chief Operations Officer | S | Common Stock | 20 | $1.11 | 265,515.0000 | 5,101,459 | 0.01% | 0.00% |
| Jan. 2, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Johnston Lloyd P. | Chief Operations Officer | A | Common Stock | 100000 | $0.00 | 275,299.0000 | 5,101,459 | 57.05% | 1.96% |
| Jan. 2, 2023 | Cartesian Therapeutics, Inc. | $RNAC | Johnston Lloyd P. | Chief Operations Officer | A | Employee Stock Option (right to buy) | 475000 | $0.00 | 475,000.0000 | 5,101,459 | 9999.99% | 9.31% |